Raphael Pharmaceutical RAPH
OTC RAPH
$1.40 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Raphael Pharmaceutical (RAPH) Receivables - Other (2023)

Raphael Pharmaceutical's (RAPH) quarterly Receivables - Other came in at $100000.0 in Q4 2023.

Analysis

Raphael Pharmaceutical (RAPH) Receivables - Other (2023) Analysis & Trends

Raphael Pharmaceutical has disclosed Receivables - Other across 1 years of filings, most recently posting $100000.0 for Q4 2023.

  • In Q4 2023, Receivables - Other changed N/A year-over-year to $100000.0; the TTM figure through Dec 2023 stood at $100000.0 (changed N/A YoY), while the FY2023 annual figure was $100000.0, changed N/A from the prior year.
  • Receivables - Other came in at $100000.0 for Q4 2023 at Raphael Pharmaceutical.
  • In the past five years, Receivables - Other ranged from a high of $100000.0 in Q4 2023 to a low of $100000.0 in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Raphael Pharmaceutical 28.25 Mn 28.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 100,000.00